Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Drake

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Molecular Biology of the Cell|February 20, 2009
ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cellsJustin M Drake, Garth Strohbehn, Thomas B Bair, et al.
Genes & Development|October 17, 2012
Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signalingTanya Stoyanova, Andrew S Goldstein, Houjian Cai, et al.
The Journal of Biological Chemistry|August 24, 2010
ZEB1 coordinately regulates laminin-332 and {beta}4 integrin expression altering the invasive phenotype of prostate cancer cellsJustin M Drake, J Matthew Barnes, Joshua M Madsen, et al.
Cancer Biology & Therapy|February 27, 2009
Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arteriolesChristine J Weydert, Alison K Esser, Ruth A Mejia, et al.
Clinical & Experimental Metastasis|December 11, 2012
Integrin α3β1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonizationAfshin Varzavand, Justin M Drake, Robert U Svensson, et al.
Frontiers in Oncology|July 17, 2023
Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPCRalph E White, Maxwell Bannister, Abderrahman Day, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Saracatinib synergizes with enzalutamide to downregulate androgen receptor activity in castration resistant prostate cancerRalph E White, Maxwell Bannister, Abderrahman Day, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancerMia Hofstad, Andrea Woods, Karla Parra, et al.
Endocrinology|February 17, 2024
Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early DetectionSong Yi Bae, Kaylee Judith Kamalanathan, Catalina Galeano-Garces, et al.
Nature Protocols|April 30, 2011
Purification and direct transformation of epithelial progenitor cells from primary human prostateAndrew S Goldstein, Justin M Drake, Daina L Burnes, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Molecular Biology of the Cell|February 20, 2009
ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cellsJustin M Drake, Garth Strohbehn, Thomas B Bair, et al.
Genes & Development|October 17, 2012
Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signalingTanya Stoyanova, Andrew S Goldstein, Houjian Cai, et al.
The Journal of Biological Chemistry|August 24, 2010
ZEB1 coordinately regulates laminin-332 and {beta}4 integrin expression altering the invasive phenotype of prostate cancer cellsJustin M Drake, J Matthew Barnes, Joshua M Madsen, et al.
Cancer Biology & Therapy|February 27, 2009
Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arteriolesChristine J Weydert, Alison K Esser, Ruth A Mejia, et al.
Clinical & Experimental Metastasis|December 11, 2012
Integrin α3β1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonizationAfshin Varzavand, Justin M Drake, Robert U Svensson, et al.
Frontiers in Oncology|July 17, 2023
Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPCRalph E White, Maxwell Bannister, Abderrahman Day, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Saracatinib synergizes with enzalutamide to downregulate androgen receptor activity in castration resistant prostate cancerRalph E White, Maxwell Bannister, Abderrahman Day, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancerMia Hofstad, Andrea Woods, Karla Parra, et al.
Endocrinology|February 17, 2024
Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early DetectionSong Yi Bae, Kaylee Judith Kamalanathan, Catalina Galeano-Garces, et al.
Nature Protocols|April 30, 2011
Purification and direct transformation of epithelial progenitor cells from primary human prostateAndrew S Goldstein, Justin M Drake, Daina L Burnes, et al.
Pageof 6